Mayo Foundation for Medical Education and Research-Pharmaceuticals & Healthcare-Deals and Alliances Profile
July 2017
42
About the Report
About the Report
Summary
Mayo Foundation for Medical Education and Research (Mayo) is a non-profit organization that provides healthcare for complex conditions through its Mayo Clinics. Mayo operates a network of hospitals, clinics and health care facilities, serving communities in Minnesota, Iowa, Georgia and Wisconsin. It also conducts research and trainings for physicians, nurses, and other health professionals. Its services include heart care, transplantation, cancer treatment, neurosciences and medical research. The foundation provides its products and services to consumer, business and professionals. Mayo's research clinics include Cancer Center, Center for Translational Science Activities (CTSA), Institutional Review Board, Clinical Trials and Research Fellow's Association. Mayo is headquartered in Rochester Minnesota, the US.
Mayo Foundation for Medical Education and Research-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Mayo Foundation for Medical Education and Research, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Qrativ Raises USD8.3 Million in Series A Financing 14
Evelo Biosciences Raises USD50 Million in Series B Financing 14
DayTwo Secures USD12 Million in Series A Funding 16
DayTwo Raises USD12 Million in Series A Financing 17
Second Genome Raises USD42.6 Million in Series B Financing 18
Unity Biotechnology Raises Funds in Venture Financing 19
AssureRx Health Raises Additional USD15 Million in Series D Financing 20
OxThera Raises USD10.7 Million In Venture Financing 21
Partnerships 22
Mayo Clinic and nference Form Joint Venture 22
Baxter International and Mayo Clinic Enter into Research Agreement 23
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23
EnBiotix Partners with Mayo Clinic 24
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 25
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25
GE Ventures Forms Joint Venture with Mayo Clinic 26
Morphotek Enters into Agreement with Mayo Clinic 27
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 28
Seres Health Enters into Research Agreement with Mayo Clinic 29
Licensing Agreements 29
Mayo Clinic Enters into Licensing Agreement with ID Pharma 29
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 30
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 31
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 32
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 33
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 34
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 35
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 35
Acquisition 36
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 36
Mayo Foundation for Medical Education and Research-Key Competitors 38
Key Employees 39
Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Recent Developments 41
Government and Public Interest 41
Feb 11, 2016: Long-term benefits of 'senolytic' drugs on vascular health in mice 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Figure
List of Figures
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10
List of Table
List of Tables
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Key Facts 1
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Foundation for Medical Education and Research, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Foundation for Medical Education and Research, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Qrativ Raises USD8.3 Million in Series A Financing 14
Evelo Biosciences Raises USD50 Million in Series B Financing 14
DayTwo Secures USD12 Million in Series A Funding 16
DayTwo Raises USD12 Million in Series A Financing 17
Second Genome Raises USD42.6 Million in Series B Financing 18
Unity Biotechnology Raises Funds in Venture Financing 19
AssureRx Health Raises Additional USD15 Million in Series D Financing 20
OxThera Raises USD10.7 Million In Venture Financing 21
Mayo Clinic and nference Form Joint Venture 22
Baxter International and Mayo Clinic Enter into Research Agreement 23
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23
EnBiotix Partners with Mayo Clinic 24
Seres Therapeutics Enters into Research Agreement with Mayo Clinic 25
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25
GE Ventures Forms Joint Venture with Mayo Clinic 26
Morphotek Enters into Agreement with Mayo Clinic 27
Second Genome Enters into Co-Development Agreement with Mayo Clinic Center for Individualized Medicine 28
Seres Health Enters into Research Agreement with Mayo Clinic 29
Mayo Clinic Enters into Licensing Agreement with ID Pharma 29
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic 30
Seres Therapeutics Enters into Licensing Agreement with Mayo Foundation for Medical Education and Research 31
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 32
WuXi Pharma Enters Into Licensing Agreement With Mayo Clinic Center for Individualized Medicine 33
Nexus CMF Enters Into Licensing Agreement With Mayo Clinic For Prosthesis Technology 34
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 35
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 35
Mayo Clinic Health System Completes Acquisition Of Fairview Red Wing 36
Mayo Foundation for Medical Education and Research, Key Competitors 38
Mayo Foundation for Medical Education and Research, Key Employees 39
Mayo Foundation for Medical Education and Research, Subsidiaries 40
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.